← All Startups
Liberate Bio Seed
AI for genetic medicine
Liberate Bio develops non-viral delivery technologies for nucleic acid cargoes, aiming to address genetic disorders.
Location
Boston, MA
Website
liberatebio.com
LinkedIn
View profile
Founder
Michael Mitchell, PhD ’14
BioinformaticsBiotechnologyGenetics
News & Funding
2025-10-15 Seed Read article
Similar Startups
Boundless Bio
Precision oncology therapeutic
Paul Mischel, MD ’91
Series C
Freenome
Blood test to detect colorectal cancer
Gabriel Otte ’11
Moderna
mRNA vaccines
Robert Langer ’70
Pyxis Oncology
Oncology medicine portfolio
Lara Sullivan ’94
Human Longevity
Early detection for longer life
Robert Hariri, MD PhD ’87
Series B
Celularity
Biotech cellular medicines
Robert Hariri, MD PhD ’87